Sort
48,018 grants matching “immunotherapy”
Bladder Cancer Program
$1,191,004Andrea Apolo · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Biomarkers and Therapeutic Targets in Tumor Microenvironment and Metastasis
$1,190,749Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Tumor Microenvironment in Cancer Progression
$1,190,749Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT)
$1,190,601Terry B Gernsheimer · University Of Washington · U01 · FY2018 · HL
Proteogenomic studies to understand mechanisms and drivers of resistance to immunotherapies
$1,190,547Amanda G Paulovich · Fred Hutchinson Cancer Center · U01 · FY2025 · CA
Development of Therapeutic Antibody for Traumatic Brain Injury
$1,190,138Mark L. Zeidel · Beth Israel Deaconess Medical Center · U01 · FY2019 · NS
Biomarker Investigations for Clinical Trials
$1,189,791Kerstin Heselmeyer · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
ANTIGEN SPECIFIC THERAPY IN CNS AUTOIMMUNE DISEASES
$1,189,682Brigham And Women'S Hospital · P01 · FY2003 · NS
UCLA SPORE IN LUNG CANCER
$1,189,000Steven M. Dubinett · University Of California Los Angeles · P50 · FY2006 · CA
Dual targeting of tumoral microenvironment and tumoral cells by blocking the IL-33/ST2 pathway
$1,188,901Sophie Paczesny · Indiana University Indianapolis · U01 · FY2018 · CA
Immune Escape in Human Cancer: Mechanisms and Therapeutic Implications
$1,188,642Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · CA
Treg-depleting immunotherapy
$1,188,595Peter David Suzdak · Sonoval Llc · R44 · FY2021 · CA
Innate inflammatory responses during pulmonary infections
$1,188,232Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Regulation of innate lymphocyte function
$1,186,884Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Quantifying Cell-Cell Interactions in the Immune System by Trans-Synaptic Labeling
$1,186,500Gabriel D Victora · Rockefeller University · DP1 · FY2019 · AI
Quantifying Cell-Cell Interactions in the Immune System by Trans-Synaptic Labeling
$1,186,500Gabriel D Victora · Rockefeller University · DP1 · FY2021 · AI
Quantifying Cell-Cell Interactions in the Immune System by Trans-Synaptic Labeling
$1,186,500Gabriel D Victora · Rockefeller University · DP1 · FY2018 · AI
Quantifying Cell-Cell Interactions in the Immune System by Trans-Synaptic Labeling
$1,186,500Gabriel D Victora · Rockefeller University · DP1 · FY2022 · AI
Quantifying Cell-Cell Interactions in the Immune System by Trans-Synaptic Labeling
$1,186,500Gabriel D Victora · Rockefeller University · DP1 · FY2020 · AI
TLR Immunotherapy to Eradicate Anatomic SIV Reservoirs
$1,186,106James Burton Whitney · Beth Israel Deaconess Medical Center · R01 · FY2017 · AI
EXPLOIT IMMUNE SIGNATURES FROM IMMUNOTHERAPY RESPONSE IN METASTATIC RENAL CELL CANCER TO IMPROVE QUALITY OF LIFE AND SURVIVAL OF VETERANS
$1,185,996The Medical University Of South Carolina · · FY2025 · Defense Health Agency
Myeloid TGFbeta signaling in breast cancer metastasis and dormancy
$1,185,828Li Yang · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Effects of systemic and topical perturbations on human microbes
$1,185,587Heidi Kong · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Bay Area Team Against Resistance
$1,185,025Trever G Bivona · University Of California, San Francisco · U54 · FY2020 · CA
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure
$1,184,950Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2021 · AI